Paradigm shifts in cardiovascular medicine.
D003327:Coronary Disease / Q000191:economics / Q000628:therapy*; D003695:Delivery of Health Care / Q000191:economics; D003953:Diagnosis-Related Groups / Q000191:economics; D016503:Drug Delivery Systems / Q000191:economics; D005260:Female; D017048:Health Care Costs; D017721:Hospital Costs / Q000706:statistics & numerical data; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007349:Insurance, Health, Reimbursement / Q000191:economics; D008297:Male; D006278:Medicare / Q000191:economics; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009204:Myocardial Revascularization / Q000191:economics / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012051:Reimbursement Mechanisms / Q000191:economics; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000191:economics; D014481:United States
D007166:Immunosuppressive Agents; D020123:Sirolimus